RE-BVS – Piemonte Repository

Sfoglia per AUTORE
BARCO A
Collezione ASL Città di Torino

Items : 7

Switching to Low Neurotoxic Antiretrovirals to Improve Neurocognition Among People Living With HIV-1-Associated Neurocognitive Disorder: The MARAND-X Randomized Clinical Trial. in Journal of acquired immune deficiency syndromes (1999) / J Acquir Immune Defic Syndr. 2024 Oct 1;97(2):180-191. doi: 10.1097/QAI.0000000000003480.

2024
ASL Città di Torino
AOU Novara

Di Perri G; Calcagno A; Bonora S; Trentalange A; Trunfio M; Giaccone C; Noce G; Ghisetti V; Tettoni MC; Nigra M; Guastamacchia G; Stroffolini G; Pirriatore V; Barco A; Lazzaro A; Vai D;

Changes in Cerebrospinal Fluid, Liver and Intima-media-thickness Biomarkers in Patients with HIV-associated Neurocognitive Disorders Randomized to a Less Neurotoxic Treatment Regimen. in Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology / J Neuroimmune Pharmacol. 2023 Dec;18(4):551-562. doi: 10.1007/s11481-023-10086-7. Epub 2023 Oct 31.

2023
ASL Città di Torino
AOU Novara

Calcagno A; Di Perri G G; Bonora S; Nigra M; Trunfio M; Atzori C; Giaccone C; Pirriatore V; Vai D; Barco A; Stroffolini G; Lazzaro A;

Correlations between cerebrospinal fluid biomarkers, neurocognitive tests, and resting-state electroencephalography (rsEEG) in patients with HIV-associated neurocognitive disorders. in Journal of neurovirology / J Neurovirol. 2022 Apr;28(2):226-235. doi: 10.1007/s13365-021-01047-y. Epub 2022 Jan 19.

2022
ASL Città di Torino

Bonora S; Trunfio M; Noce G; Atzori C; Guastamacchia G; Vai D; Lazzaro A; Pirriatore V; Stroffolini G; Orlando S; Barco A; Di Perri G; Calcagno A;

BCGitis after Bacille Calmette-Guerin intravesical administration from two referral centers: clinical characteristics and risk factors. in Le infezioni in medicina / Infez Med. 2022 Jun 1;30(2):242-246. doi: 10.53854/liim-3002-9. eCollection 2022.

2022
ASL Città di Torino
AOU Novara

Di Perri G; Bonora S; Bonfanti P; Lupia T; Lapadula G; Rossi M; Barco A; De Benedetto I; Calcagno A;

Rifampicin and Isoniazid Maximal Concentrations are Below Efficacy-associated Thresholds in the Majority of Patients: Time to Increase the Doses? in International journal of antimicrobial agents / Int J Antimicrob Agents. 2021 Mar;57(3):106297. doi: 10.1016/j.ijantimicag.2021.106297. Epub 2021 Fe

2021
ASL Città di Torino

Bonora S; Di Perri G; D'Avolio A; Piccioni P; De Nicolò A; Barco A; Rossi G; Costa C; Pirriatore V; Antonucci M; Motta I; Borgogno E; Trentalange A; Calcagno A;

Cerebral white matter Hyperintensities in HIV-positive patients. in Brain imaging and behavior / Brain Imaging Behav. 2020 Feb;14(1):10-18. doi: 10.1007/s11682-018-9966-1.

2020
ASL Città di Torino

Di Perri G; Bonora S; Barco A; Nunnari G; Tettoni M; Imperiale D; Cusato J; Prochet A; Trentalange A; Calcagno A;

CNS-Targeted Antiretroviral Strategies: When Are They Needed and What to Choose. in Current HIV/AIDS reports / Curr HIV/AIDS Rep. 2018 Feb;15(1):84-91. doi: 10.1007/s11904-018-0375-2.

2018
ASL Città di Torino

Calcagno A; Barco A; Trunfio M; Bonora S;